Not provided
Not provided
Not provided
Not provided
low rate recruitment
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| European Commission | OTHER |
| Zoll Medical Corporation | INDUSTRY |
Not provided
Not provided
Not provided
AMSA trial is a multicenter, randomized, controlled study in out-of-hospital cardiac arrest patients.
The purpose of the study is to test the hypothesis that a real time AMSA analysis during CPR may predict the success of defibrillation and optimize the timing of defibrillation delivery.
The primary end-point is the efficacy of the AMSA-CPR: termination of VF/VT with achievement of ROSC for an AMSA ≥ 15.5 mV-Hz
All patients meeting inclusion/exclusion criteria and receiving cardiopulmonary resuscitation are randomized into two groups: AMSA-guided CPR or standard CPR.
In the AMSA-CPR group, AMSA value suggests when the rescuer should deliver the defibrillation attempt; In the Standard-CPR group, the defibrillation is delivered based on the 2015 European Resuscitation Council (ERC) CPR guidelines.
In the AMSA-CPR intervention, upon arrival of the advanced life support (ALS) rescue team at the cardiac arrest scene and application of the defibrillatory pads to the patient's chest and power on of the defibrillator with the real time AMSA analysis:
After completion of the first 2-min CPR cycle:
After completion of the second 2-min CPR cycle and till the end of the resuscitative intervention:
• CPR is continued based on standard 2015 ERC guidelines (a defibrillation attempt every 2-min CPR cycles), except for the possibility to anticipate the defibrillation attempt if AMSA becomes ≥ 15.5 mV-Hz during the CPR cycle.
In the standard CPR intervention, upon arrival of the ALS team at the cardiac arrest scene, and application of the defibrillatory pads to the patient's chest and power on of the defibrillator:
• a defibrillation is immediately attempted and CPR is then started and continued for 2- min. Analysis of rhythm and subsequent defibrillation attempts are performed every 2-min CPR cycles.
In both study groups, the quality of CC and ventilation is monitored in real time thought the feedback integrated into the defibrillator.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| AMSA-CPR | Experimental | The professional rescuer decides to deliver the defibrillation attempt based on the AMSA value displayed in the defibrillator |
|
| Standard-CPR | Active Comparator | The defibrillation is delivered based on the 2015 European Resuscitation Council CPR guidelines |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| AMSA | Diagnostic Test | A non-invasive and real time VF (Amplitude Spectrum Area) AMSA analysis is performed during chest compression pauses for delivery of 2 ventilations, from the ECG acquired from the conventional defibrillatory pads |
| Measure | Description | Time Frame |
|---|---|---|
| Return of spontaneous circulation (ROSC) | Termination of ventricular fibrillation with achievement of ROSC for an AMSA value ≥ 15.5 mV-Hz | At day 0: from date of initiation of the cardiopulmonary resuscitation (CPR) maneuvres up to ROSC or up to 1 hour of CPR (which comes first) |
| Measure | Description | Time Frame |
|---|---|---|
| Defibrillation attempts | Number of defibrillations to achieve ROSC | At day 0: from date of initiation of the cardiopulmonary resuscitation (CPR) maneuvres up to ROSC or up to 1 hour of CPR (which comes first) |
| CPR duration |
Not provided
Inclusion Criteria:
All adult patients (age ≥ 18) suffering of out-of-hospital non traumatic cardiac arrest of presumably cardiac etiology with a presenting shockable rhythm requiring electrical defibrillation: Ventricular Fibrillation and pulseless Ventricular Tachycardia.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Giuseppe Ristagno, MD, PhD | Istituto Di Ricerche Farmacologiche Mario Negri | Study Chair |
| Roberto Latini, MD | Istituto Di Ricerche Farmacologiche Mario Negri | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| UOC Rianimazione-Emergenza Territoriale 118, Dipartimento di Emergenza, Ospedale Maggiore - AUSL di Bologna | Bologna | 40124 | Italy | |||
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 36977371 | Derived | Ruggeri L, Fumagalli F, Bernasconi F, Semeraro F, Meessen JMTA, Blanda A, Migliari M, Magliocca A, Gordini G, Fumagalli R, Sechi G, Pesenti A, Skrifvars MB, Li Y, Latini R, Wik L, Ristagno G. Amplitude Spectrum Area of ventricular fibrillation to guide defibrillation: a small open-label, pseudo-randomized controlled multicenter trial. EBioMedicine. 2023 Apr;90:104544. doi: 10.1016/j.ebiom.2023.104544. Epub 2023 Mar 26. |
| Label | URL |
|---|---|
| EU Framework Horizon 2020 Programme under grant agreement no. 733381: European Sudden Cardiac Arrest network: towards Prevention, Education and New Treatment (ESCAPE-NET) | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D058687 | Out-of-Hospital Cardiac Arrest |
| D014693 | Ventricular Fibrillation |
| D006323 | Heart Arrest |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D001145 | Arrhythmias, Cardiac |
| D010335 | Pathologic Processes |
Not provided
Not provided
| ID | Term |
|---|---|
| D004554 | Electric Countershock |
| D016887 | Cardiopulmonary Resuscitation |
| ID | Term |
|---|---|
| D004599 | Electric Stimulation Therapy |
| D013812 | Therapeutics |
| D012151 | Resuscitation |
| D004638 | Emergency Treatment |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Defibrillation | Procedure | delivery of the defibrillation is attempted to terminate VF either based on AMSA value (in the AMSA-CPR arm) or every 2-min CPR cycle as recommended by current guidelines (in the Standard-CPR arm) |
|
|
| CPR | Procedure | chest compressions and ventilations at a rate of 30:2 |
|
|
duration of CPR in minutes prior to achieve ROSC
| At day 0: from date of initiation of the cardiopulmonary resuscitation (CPR) maneuvres up to ROSC or up to 1 hour of CPR (which comes first) |
| Cardiac troponins | assessment of circulating levels of high sensitive cardiac troponin T in plasma as marker of cardiac injury | at 6 and 24 hours after ICU admission |
| Short term survival | number of patients alive after initial resuscitation | at hospital admission and 24 hours after ROSC |
| Long term survival | number of patients alive after initial resuscitation | at 1 and 6 months after ROSC |
| SOREU Metropolitana - AREU ASST, Grande Ospedale Metropolitano Niguarda |
| Milan |
| 20162 |
| Italy |
| ESCAPE NET in ERC website | View source |
| D013568 |
| Pathological Conditions, Signs and Symptoms |